MetaCap

DataMeds AI Inc. (MEDS)

NASDAQ: MEDSHealth CareOther PharmaceuticalsUSD

1.34+0.6123 (+84.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MEDS stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$18.39
52-week range
0.493 – 33.15
Day range
0.8552 – 1.43
Volume / Avg
89.98M / 8.43M
Beta
—

52-week range

$0.493$33.15

MEDS stock today

DataMeds AI (MEDS) closed at $1.34 on Nov 20, up 84.14% (+$0.6123), versus the S&P 500's 3.70% decline. Volume was 10.7x the average at 89.98M shares, a sign of unusually heavy trading. Shares are 96.0% below their 52-week high of $33.15 and 171.8% above the 52-week low of $0.493, near the bottom of the past year's range.

DataMeds AI has posted a net loss over the last twelve months (EPS of -$18.39), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About DataMeds AI

Company profile

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers.

Industry
Other Pharmaceuticals
CEO
Mr. Prashant Patel M.Sc., R.Ph.
Headquarters
Tampa, FL
IPO year
2025

Financial highlights

Full financials

In fiscal 2025, DataMeds AI generated $23.3 million in revenue, up 28.7% from fiscal 2024. DataMeds AI reported a net loss of $101.3 million, compared with a loss of $6.9 million a year earlier. Gross margin was -27.5% (down from 9.7%) and operating margin -401.7%.

DataMeds AI annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023
Revenue$23.34M$18.13M—
Growth+28.73%——
Net income$-101.27M$-6.86M$-2.90M
EPS (diluted)$-1.43$-0.15$-0.06

Earnings

Earnings history
Last reported (Sep/2026)
Nov 18, 2026
EPS actual vs est.
$2.72 vs —

MEDS news

All MEDS news

DataMeds AI peers

Health Care sector
MEDS peer companies
CompanyPrice% ChgMarket capCompare
HKPDCellyan Biotechnology Co. Ltd Class A1.38+2.60%$3.40Mvs MEDS
COSMCosmos Health Inc.2.81-2.09%$14.14Mvs MEDS
ESYNEnerSyn Global Inc.1.11-0.89%$37.44Mvs MEDS
NUSNu Skin Enterprises Inc.3.80+0.80%$184.98Mvs MEDS
HLFHerbalife Ltd.15.53-0.26%$1.63Bvs MEDS
CAHCardinal Health Inc.272.81+0.17%$63.06Bvs MEDS
CORCencora Inc.339.09-0.63%$64.71Bvs MEDS
MCKMcKesson Corporation1,069.43+0.68%$123.47Bvs MEDS

Indexes, lists and sector

DataMeds AI stock FAQ

What is DataMeds AI's stock price today?

MEDS last traded at $1.34 as of Nov 20, 4:00 PM EST, up 84.14% on the day. Prices are delayed at least 15 minutes.

Who is DataMeds AI's CEO?

Mr. Prashant Patel M.Sc., R.Ph. is the chief executive officer of DataMeds AI Inc..

What is the MEDS 52-week high?

The 52-week high for MEDS is $33.15 and the 52-week low is $0.493. The stock is currently 96.0% below its high.

Compare MEDS